GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Odonate Inc (OTCPK:ODTC) » Definitions » YoY EPS Growth

Odonate (Odonate) YoY EPS Growth : 60.22% (As of Sep. 2021)


View and export this data going back to 2017. Start your Free Trial

What is Odonate YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Odonate's YoY EPS Growth for the quarter that ended in Sep. 2021 was 60.22%.

Odonate's Earnings per Share (Diluted) for the three months ended in Sep. 2021 was $-3,700.00.


Odonate YoY EPS Growth Historical Data

The historical data trend for Odonate's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Odonate YoY EPS Growth Chart

Odonate Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
YoY EPS Growth
Get a 7-Day Free Trial -1,852.53 -1,913.48 -57.58 -11.26 5.19

Odonate Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.68 6.67 9.09 46.79 60.22

Odonate YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Odonate's YoY EPS Growth for the fiscal year that ended in Dec. 2020 is calculated as:

YoY EPS Growth (A: Dec. 2020 )
=(Earnings per Share (Diluted) (A: Dec. 2020 )-Earnings per Share (Diluted) (A: Dec. 2019 ))/ | Earnings per Share (Diluted) (A: Dec. 2019 ) |
=(-38400--40500)/ | -40500 |
=5.19 %

Odonate's YoY EPS Growth for the quarter that ended in Sep. 2021 is calculated as:

YoY EPS Growth (Q: Sep. 2021 )
=(Earnings per Share (Diluted) (Q: Sep. 2021 )-Earnings per Share (Diluted) (Q: Sep. 2020 )) / | Earnings per Share (Diluted) (Q: Sep. 2020 )) |
=(-3700--9300)/ | -9300 |
=60.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Odonate YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Odonate's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Odonate (Odonate) Business Description

Traded in Other Exchanges
N/A
Address
3 East 28th Street, 10th Floor, New York, NY, USA, 10016
Odonate Inc is a Shell company.
Executives
Ecor1 Capital, Llc 10 percent owner 357 TEHAMA STREET #3, SAN FRANCISCO CA 94103
Boxer Capital, Llc director, 10 percent owner 12860 EL CAMINO REAL, SUITE 300, SAN DIEGO CA 92130
Kevin C Tang director, 10 percent owner, officer: Chief Executive Officer 4747 EXECUTIVE DRIVE, SUITE 210, SAN DIEGO CA 92121
Aaron I. Davis director, 10 percent owner 12860 EL CAMINO REAL, SUITE 300, SAN DIEGO CA 92130
Craig A Johnson director C/O PURE BIOSCIENCE, 1725 GILLESPIE WAY, EL CAJON CA 92020
Jeff L Vacirca director 4747 EXECUTIVE DRIVE, SUITE 510, SAN DIEGO CA 92121
Laura L. Johnson director C/O LA JOLLA PHARMACEUTICAL COMPANY, LA JOLLA VILLAGE DRIVE, SUITE 1070, SAN DIEGO CA 92122
Michael S Hearne officer: Chief Financial Officer 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Joseph P O'connell officer: Chief Medical Officer 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Boxer Asset Management Inc. 10 percent owner CAY HOUSE, EP TAYLOR DRIVE N7776, LYFORD CAY, NEW PROVIDENCE C5 00000
Robert Rosen director C/O HERON THERAPEUTICS, INC, 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO CA 92121
Joseph Lewis 10 percent owner PO BOX N7776, LYFORD BAHAMAS
Tang Capital Management Llc 10 percent owner 4747 EXECUTIVE DRIVE, SUITE 210, SAN DIEGO CA 92121
Tang Capital Partners Lp 10 percent owner 4747 EXECUTIVE DRIVE, SUITE 210, SAN DIEGO CA 92121
John G Lemkey officer: Chief Financial Officer 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121

Odonate (Odonate) Headlines

From GuruFocus

Odonate Announces Expected Delisting of Its Stock

By Business Wire Business Wire 01-07-2022

Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Sold $5.7 million of Shares

By GuruFocus Research GuruFocus Editor 11-20-2021